@BrokenOfBritain Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@peds_id_doc Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@HIPAA_School Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@vj_CR Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@FundacionCiEM Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@FEMSSG Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@brianvastag Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Modelsofdisease Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@MossbergLabs Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@CanLyme Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@BiosysScientifi Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@cancer_network Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@AdvClinical Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Jayson_Parker Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@kevinconway_ Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@nhssm Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness #ukpoli
@nhsinstituteuk Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@PCTNetwork Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@NHSmanagers Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@YourChoicenhs Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@sallygainsbury Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@brainstrust Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Number10gov Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@NHSWebteam Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness RT
@CathyCecere Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@APAPsychiatric Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@PatientTortRpt Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@CharlesSpillane Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@douglasridgway Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@PartnershipsCT Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Nigelhawkes Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@tompaulson Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@ISBLeeHood Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@KingsCollegeLon Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@ojcius Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Cell_Biology_WB Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@SamListerTimes Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@DrNancyNBCNEWS Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@clarercgp Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@guardian Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@PNASNews Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@ubiquitin_neuro Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@FMaware Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@MRCcomms Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@WebmedCentral Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@DrChrisSteele Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@suzanne_moore Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@OpenMedicine Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@WCBADoctorBrian Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@DrKevinConners Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@MarkEnglish Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@EvidenceNetwork Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@HematologyMed Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@pipelinereview Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@medicalmalprac1 Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4illness
@CanadaQBank Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@ubcchcm Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@ojcius Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@IRBAdvisor Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@EmilyHolton Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@JasonBellakMD Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@chromocyte Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@CHRTumich Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@GPtools_org Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@WebmedCentral Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@michaelchatman Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@researchimpact Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@StanfordHosp Patients w #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@Reuters_Health Patients w #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@womenshealth Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@CDCgov Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@NIHforHealth Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@FDALawyers Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
RT @XMRV_GA: @SocietyGuardian Patients w #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@DrOz Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@WebMD_News Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@medlineplus Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness
@SocietyGuardian Patients w #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence 4 illness
@NEJM Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@bmj_latest Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@nhsdirect Patients with #MECFS need larger clinical trials with Rituximab. http://t.co/uNMcrwAF this is very strong evidence for illness.
@guardiannews Pts with #MECFS are thrilled that the norwegians take ME seriously just like other autoimmune diseases http://t.co/uNMcrwAF
Neuroscience and Pain Science for Manual Physical Therapists Via Ole, "Benefit from B-Lymphocyte Depletion Using... http://t.co/3vJkEHuH
RT @dfjpt: Via Ole, "Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome.... http://t.co/gJJOhhgq
Via Ole, "Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome.... http://t.co/gJJOhhgq
Hurra for Fluge, Mella og Haukeland! Sannsynlig at ME ikke kan forklares med faktorer "over snippen". http://t.co/n9Dl1Lr2
MT @velogubbed latest Norwegian research into #mecfs http://t.co/AMBCqVT2
@toresalte grubler på hvor sikre er vi på blindingen: Kjenner du noen i miljøet som har gjort studien? http://t.co/N6LjOqM3
RT @SigMik: Link to the #Rituximab paper on myalgic encephalomyelitis / chronic fatigue disorder in PLosOne: http://t.co/648Qad2k #ME #CFS
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A... http://t.co/6hnLhAuT
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A... http://t.co/SBSiQKTm
RT @MEAssociation: Link to the full Rituximab paper in PLosOne: http://t.co/PIqZKkyR #mecfs #cfs #xmrv #rituximab
Here's the study on Rituximab/Rituxan in ME/CFS that shows major improvement in 67 % of patients http://t.co/ybkOSkvg #ME #CFS
Link to the #Rituximab paper on myalgic encephalomyelitis / chronic fatigue disorder in PLosOne: http://t.co/648Qad2k #ME #CFS
RT @XMRV_GA: #rheum Patients with #mecfs (aka chronic fatigue syndrome) helped by Rituximab. Could you please help us? http://t.co/DLnqRYYN
RT @XMRV_GA: Rituximab shownto help patient with #MECFS... But is Roche interested to help them? Roche, do the right thing. http://t.co/DLnqRYYN
Genuinely interested to know if #ME #CFS patients still believe #XMRV is a cause of this condition? http://t.co/gRySFMNa
Good proof-of-principle study for Ph2 study of rituximab for #ME #CFS http://t.co/gRySFMNa More Ph2 and then Ph3 #takestimefolks
"CFS is a disease of unknown aetiology." As almost all autoimmune diseases...... http://t.co/0xjZ5vcP
No virus in CFS? @profvrr Have you seen this study on rituximab in CFS? http://t.co/0xjZ5vcP Suggests CFS is an autoimmune disease.